Global Drug-Induced Dyskinesia Market Research Report 2026(Status and Outlook)
Drug-Induced Dyskinesia refers to involuntary, abnormal movements of the face, limbs, or body caused as a side effect of certain medications, most commonly those that affect dopamine pathways such as antipsychotics or drugs used in Parkinson?s disease. These movements can include tremors, tics, twisting motions, or repetitive movements, and may be temporary or persistent depending on the drug exposure and patient susceptibility.
The global Drug-Induced Dyskinesia market size was estimated at USD 372.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Drug-Induced Dyskinesia market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Drug-Induced Dyskinesia market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drug-Induced Dyskinesia market.
Global Drug-Induced Dyskinesia Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Neurocrine Bioscience
Teva Pharmaceuticals
Sun Pharmaceutical Industries
SteriMax
Lannett
Adamas Pharmaceuticals
Sanis
AbbVie
Market Segmentation (by Type)
VMAT2 Inhibitors
Dopamine-Depleting Medications
Other
Market Segmentation (by Application)
Hospitals
Clinic
Other
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug-Induced Dyskinesia Market
Overview of the regional outlook of the Drug-Induced Dyskinesia Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Induced Dyskinesia Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug-Induced Dyskinesia, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Drug-Induced Dyskinesia market size was estimated at USD 372.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Drug-Induced Dyskinesia market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Drug-Induced Dyskinesia market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drug-Induced Dyskinesia market.
Global Drug-Induced Dyskinesia Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Neurocrine Bioscience
Teva Pharmaceuticals
Sun Pharmaceutical Industries
SteriMax
Lannett
Adamas Pharmaceuticals
Sanis
AbbVie
Market Segmentation (by Type)
VMAT2 Inhibitors
Dopamine-Depleting Medications
Other
Market Segmentation (by Application)
Hospitals
Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug-Induced Dyskinesia Market
Overview of the regional outlook of the Drug-Induced Dyskinesia Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Induced Dyskinesia Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug-Induced Dyskinesia, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Drug-Induced Dyskinesia
1.2 Key Market Segments
1.2.1 Drug-Induced Dyskinesia Segment by Type
1.2.2 Drug-Induced Dyskinesia Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG-INDUCED DYSKINESIA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug-Induced Dyskinesia Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Drug-Induced Dyskinesia Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG-INDUCED DYSKINESIA MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Drug-Induced Dyskinesia Product Life Cycle
3.3 Global Drug-Induced Dyskinesia Sales by Manufacturers (2020-2025)
3.4 Global Drug-Induced Dyskinesia Revenue Market Share by Manufacturers (2020-2025)
3.5 Drug-Induced Dyskinesia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drug-Induced Dyskinesia Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Drug-Induced Dyskinesia Market Competitive Situation and Trends
3.8.1 Drug-Induced Dyskinesia Market Concentration Rate
3.8.2 Global 5 and 10 Largest Drug-Induced Dyskinesia Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DRUG-INDUCED DYSKINESIA INDUSTRY CHAIN ANALYSIS
4.1 Drug-Induced Dyskinesia Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG-INDUCED DYSKINESIA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drug-Induced Dyskinesia Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Drug-Induced Dyskinesia Market
5.7 ESG Ratings of Leading Companies
6 DRUG-INDUCED DYSKINESIA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Induced Dyskinesia Sales Market Share by Type (2020-2025)
6.3 Global Drug-Induced Dyskinesia Market Size by Type (2020-2025)
6.4 Global Drug-Induced Dyskinesia Price by Type (2020-2025)
7 DRUG-INDUCED DYSKINESIA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Induced Dyskinesia Market Sales by Application (2020-2025)
7.3 Global Drug-Induced Dyskinesia Market Size (M USD) by Application (2020-2025)
7.4 Global Drug-Induced Dyskinesia Sales Growth Rate by Application (2020-2025)
8 DRUG-INDUCED DYSKINESIA MARKET SALES BY REGION
8.1 Global Drug-Induced Dyskinesia Sales by Region
8.1.1 Global Drug-Induced Dyskinesia Sales by Region
8.1.2 Global Drug-Induced Dyskinesia Sales Market Share by Region
8.2 Global Drug-Induced Dyskinesia Market Size by Region
8.2.1 Global Drug-Induced Dyskinesia Market Size by Region
8.2.2 Global Drug-Induced Dyskinesia Market Size by Region
8.3 North America
8.3.1 North America Drug-Induced Dyskinesia Sales by Country
8.3.2 North America Drug-Induced Dyskinesia Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Drug-Induced Dyskinesia Sales by Country
8.4.2 Europe Drug-Induced Dyskinesia Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Drug-Induced Dyskinesia Sales by Region
8.5.2 Asia Pacific Drug-Induced Dyskinesia Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Drug-Induced Dyskinesia Sales by Country
8.6.2 South America Drug-Induced Dyskinesia Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Drug-Induced Dyskinesia Sales by Region
8.7.2 Middle East and Africa Drug-Induced Dyskinesia Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DRUG-INDUCED DYSKINESIA MARKET PRODUCTION BY REGION
9.1 Global Production of Drug-Induced Dyskinesia by Region(2020-2025)
9.2 Global Drug-Induced Dyskinesia Revenue Market Share by Region (2020-2025)
9.3 Global Drug-Induced Dyskinesia Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Drug-Induced Dyskinesia Production
9.4.1 North America Drug-Induced Dyskinesia Production Growth Rate (2020-2025)
9.4.2 North America Drug-Induced Dyskinesia Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Drug-Induced Dyskinesia Production
9.5.1 Europe Drug-Induced Dyskinesia Production Growth Rate (2020-2025)
9.5.2 Europe Drug-Induced Dyskinesia Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Drug-Induced Dyskinesia Production (2020-2025)
9.6.1 Japan Drug-Induced Dyskinesia Production Growth Rate (2020-2025)
9.6.2 Japan Drug-Induced Dyskinesia Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Drug-Induced Dyskinesia Production (2020-2025)
9.7.1 China Drug-Induced Dyskinesia Production Growth Rate (2020-2025)
9.7.2 China Drug-Induced Dyskinesia Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Neurocrine Bioscience
10.1.1 Neurocrine Bioscience Basic Information
10.1.2 Neurocrine Bioscience Drug-Induced Dyskinesia Product Overview
10.1.3 Neurocrine Bioscience Drug-Induced Dyskinesia Product Market Performance
10.1.4 Neurocrine Bioscience Business Overview
10.1.5 Neurocrine Bioscience SWOT Analysis
10.1.6 Neurocrine Bioscience Recent Developments
10.2 Teva Pharmaceuticals
10.2.1 Teva Pharmaceuticals Basic Information
10.2.2 Teva Pharmaceuticals Drug-Induced Dyskinesia Product Overview
10.2.3 Teva Pharmaceuticals Drug-Induced Dyskinesia Product Market Performance
10.2.4 Teva Pharmaceuticals Business Overview
10.2.5 Teva Pharmaceuticals SWOT Analysis
10.2.6 Teva Pharmaceuticals Recent Developments
10.3 Sun Pharmaceutical Industries
10.3.1 Sun Pharmaceutical Industries Basic Information
10.3.2 Sun Pharmaceutical Industries Drug-Induced Dyskinesia Product Overview
10.3.3 Sun Pharmaceutical Industries Drug-Induced Dyskinesia Product Market Performance
10.3.4 Sun Pharmaceutical Industries Business Overview
10.3.5 Sun Pharmaceutical Industries SWOT Analysis
10.3.6 Sun Pharmaceutical Industries Recent Developments
10.4 SteriMax
10.4.1 SteriMax Basic Information
10.4.2 SteriMax Drug-Induced Dyskinesia Product Overview
10.4.3 SteriMax Drug-Induced Dyskinesia Product Market Performance
10.4.4 SteriMax Business Overview
10.4.5 SteriMax Recent Developments
10.5 Lannett
10.5.1 Lannett Basic Information
10.5.2 Lannett Drug-Induced Dyskinesia Product Overview
10.5.3 Lannett Drug-Induced Dyskinesia Product Market Performance
10.5.4 Lannett Business Overview
10.5.5 Lannett Recent Developments
10.6 Adamas Pharmaceuticals
10.6.1 Adamas Pharmaceuticals Basic Information
10.6.2 Adamas Pharmaceuticals Drug-Induced Dyskinesia Product Overview
10.6.3 Adamas Pharmaceuticals Drug-Induced Dyskinesia Product Market Performance
10.6.4 Adamas Pharmaceuticals Business Overview
10.6.5 Adamas Pharmaceuticals Recent Developments
10.7 Sanis
10.7.1 Sanis Basic Information
10.7.2 Sanis Drug-Induced Dyskinesia Product Overview
10.7.3 Sanis Drug-Induced Dyskinesia Product Market Performance
10.7.4 Sanis Business Overview
10.7.5 Sanis Recent Developments
10.8 AbbVie
10.8.1 AbbVie Basic Information
10.8.2 AbbVie Drug-Induced Dyskinesia Product Overview
10.8.3 AbbVie Drug-Induced Dyskinesia Product Market Performance
10.8.4 AbbVie Business Overview
10.8.5 AbbVie Recent Developments
11 DRUG-INDUCED DYSKINESIA MARKET FORECAST BY REGION
11.1 Global Drug-Induced Dyskinesia Market Size Forecast
11.2 Global Drug-Induced Dyskinesia Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Drug-Induced Dyskinesia Market Size Forecast by Country
11.2.3 Asia Pacific Drug-Induced Dyskinesia Market Size Forecast by Region
11.2.4 South America Drug-Induced Dyskinesia Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Drug-Induced Dyskinesia by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Drug-Induced Dyskinesia Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Drug-Induced Dyskinesia by Type (2026-2035)
12.1.2 Global Drug-Induced Dyskinesia Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Drug-Induced Dyskinesia by Type (2026-2035)
12.2 Global Drug-Induced Dyskinesia Market Forecast by Application (2026-2035)
12.2.1 Global Drug-Induced Dyskinesia Sales (K MT) Forecast by Application
12.2.2 Global Drug-Induced Dyskinesia Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Drug-Induced Dyskinesia
1.2 Key Market Segments
1.2.1 Drug-Induced Dyskinesia Segment by Type
1.2.2 Drug-Induced Dyskinesia Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG-INDUCED DYSKINESIA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug-Induced Dyskinesia Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Drug-Induced Dyskinesia Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG-INDUCED DYSKINESIA MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Drug-Induced Dyskinesia Product Life Cycle
3.3 Global Drug-Induced Dyskinesia Sales by Manufacturers (2020-2025)
3.4 Global Drug-Induced Dyskinesia Revenue Market Share by Manufacturers (2020-2025)
3.5 Drug-Induced Dyskinesia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drug-Induced Dyskinesia Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Drug-Induced Dyskinesia Market Competitive Situation and Trends
3.8.1 Drug-Induced Dyskinesia Market Concentration Rate
3.8.2 Global 5 and 10 Largest Drug-Induced Dyskinesia Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DRUG-INDUCED DYSKINESIA INDUSTRY CHAIN ANALYSIS
4.1 Drug-Induced Dyskinesia Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG-INDUCED DYSKINESIA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drug-Induced Dyskinesia Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Drug-Induced Dyskinesia Market
5.7 ESG Ratings of Leading Companies
6 DRUG-INDUCED DYSKINESIA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Induced Dyskinesia Sales Market Share by Type (2020-2025)
6.3 Global Drug-Induced Dyskinesia Market Size by Type (2020-2025)
6.4 Global Drug-Induced Dyskinesia Price by Type (2020-2025)
7 DRUG-INDUCED DYSKINESIA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Induced Dyskinesia Market Sales by Application (2020-2025)
7.3 Global Drug-Induced Dyskinesia Market Size (M USD) by Application (2020-2025)
7.4 Global Drug-Induced Dyskinesia Sales Growth Rate by Application (2020-2025)
8 DRUG-INDUCED DYSKINESIA MARKET SALES BY REGION
8.1 Global Drug-Induced Dyskinesia Sales by Region
8.1.1 Global Drug-Induced Dyskinesia Sales by Region
8.1.2 Global Drug-Induced Dyskinesia Sales Market Share by Region
8.2 Global Drug-Induced Dyskinesia Market Size by Region
8.2.1 Global Drug-Induced Dyskinesia Market Size by Region
8.2.2 Global Drug-Induced Dyskinesia Market Size by Region
8.3 North America
8.3.1 North America Drug-Induced Dyskinesia Sales by Country
8.3.2 North America Drug-Induced Dyskinesia Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Drug-Induced Dyskinesia Sales by Country
8.4.2 Europe Drug-Induced Dyskinesia Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Drug-Induced Dyskinesia Sales by Region
8.5.2 Asia Pacific Drug-Induced Dyskinesia Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Drug-Induced Dyskinesia Sales by Country
8.6.2 South America Drug-Induced Dyskinesia Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Drug-Induced Dyskinesia Sales by Region
8.7.2 Middle East and Africa Drug-Induced Dyskinesia Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DRUG-INDUCED DYSKINESIA MARKET PRODUCTION BY REGION
9.1 Global Production of Drug-Induced Dyskinesia by Region(2020-2025)
9.2 Global Drug-Induced Dyskinesia Revenue Market Share by Region (2020-2025)
9.3 Global Drug-Induced Dyskinesia Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Drug-Induced Dyskinesia Production
9.4.1 North America Drug-Induced Dyskinesia Production Growth Rate (2020-2025)
9.4.2 North America Drug-Induced Dyskinesia Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Drug-Induced Dyskinesia Production
9.5.1 Europe Drug-Induced Dyskinesia Production Growth Rate (2020-2025)
9.5.2 Europe Drug-Induced Dyskinesia Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Drug-Induced Dyskinesia Production (2020-2025)
9.6.1 Japan Drug-Induced Dyskinesia Production Growth Rate (2020-2025)
9.6.2 Japan Drug-Induced Dyskinesia Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Drug-Induced Dyskinesia Production (2020-2025)
9.7.1 China Drug-Induced Dyskinesia Production Growth Rate (2020-2025)
9.7.2 China Drug-Induced Dyskinesia Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Neurocrine Bioscience
10.1.1 Neurocrine Bioscience Basic Information
10.1.2 Neurocrine Bioscience Drug-Induced Dyskinesia Product Overview
10.1.3 Neurocrine Bioscience Drug-Induced Dyskinesia Product Market Performance
10.1.4 Neurocrine Bioscience Business Overview
10.1.5 Neurocrine Bioscience SWOT Analysis
10.1.6 Neurocrine Bioscience Recent Developments
10.2 Teva Pharmaceuticals
10.2.1 Teva Pharmaceuticals Basic Information
10.2.2 Teva Pharmaceuticals Drug-Induced Dyskinesia Product Overview
10.2.3 Teva Pharmaceuticals Drug-Induced Dyskinesia Product Market Performance
10.2.4 Teva Pharmaceuticals Business Overview
10.2.5 Teva Pharmaceuticals SWOT Analysis
10.2.6 Teva Pharmaceuticals Recent Developments
10.3 Sun Pharmaceutical Industries
10.3.1 Sun Pharmaceutical Industries Basic Information
10.3.2 Sun Pharmaceutical Industries Drug-Induced Dyskinesia Product Overview
10.3.3 Sun Pharmaceutical Industries Drug-Induced Dyskinesia Product Market Performance
10.3.4 Sun Pharmaceutical Industries Business Overview
10.3.5 Sun Pharmaceutical Industries SWOT Analysis
10.3.6 Sun Pharmaceutical Industries Recent Developments
10.4 SteriMax
10.4.1 SteriMax Basic Information
10.4.2 SteriMax Drug-Induced Dyskinesia Product Overview
10.4.3 SteriMax Drug-Induced Dyskinesia Product Market Performance
10.4.4 SteriMax Business Overview
10.4.5 SteriMax Recent Developments
10.5 Lannett
10.5.1 Lannett Basic Information
10.5.2 Lannett Drug-Induced Dyskinesia Product Overview
10.5.3 Lannett Drug-Induced Dyskinesia Product Market Performance
10.5.4 Lannett Business Overview
10.5.5 Lannett Recent Developments
10.6 Adamas Pharmaceuticals
10.6.1 Adamas Pharmaceuticals Basic Information
10.6.2 Adamas Pharmaceuticals Drug-Induced Dyskinesia Product Overview
10.6.3 Adamas Pharmaceuticals Drug-Induced Dyskinesia Product Market Performance
10.6.4 Adamas Pharmaceuticals Business Overview
10.6.5 Adamas Pharmaceuticals Recent Developments
10.7 Sanis
10.7.1 Sanis Basic Information
10.7.2 Sanis Drug-Induced Dyskinesia Product Overview
10.7.3 Sanis Drug-Induced Dyskinesia Product Market Performance
10.7.4 Sanis Business Overview
10.7.5 Sanis Recent Developments
10.8 AbbVie
10.8.1 AbbVie Basic Information
10.8.2 AbbVie Drug-Induced Dyskinesia Product Overview
10.8.3 AbbVie Drug-Induced Dyskinesia Product Market Performance
10.8.4 AbbVie Business Overview
10.8.5 AbbVie Recent Developments
11 DRUG-INDUCED DYSKINESIA MARKET FORECAST BY REGION
11.1 Global Drug-Induced Dyskinesia Market Size Forecast
11.2 Global Drug-Induced Dyskinesia Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Drug-Induced Dyskinesia Market Size Forecast by Country
11.2.3 Asia Pacific Drug-Induced Dyskinesia Market Size Forecast by Region
11.2.4 South America Drug-Induced Dyskinesia Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Drug-Induced Dyskinesia by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Drug-Induced Dyskinesia Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Drug-Induced Dyskinesia by Type (2026-2035)
12.1.2 Global Drug-Induced Dyskinesia Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Drug-Induced Dyskinesia by Type (2026-2035)
12.2 Global Drug-Induced Dyskinesia Market Forecast by Application (2026-2035)
12.2.1 Global Drug-Induced Dyskinesia Sales (K MT) Forecast by Application
12.2.2 Global Drug-Induced Dyskinesia Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drug-Induced Dyskinesia Market Size by Type (M USD)
Table 4. Global Drug-Induced Dyskinesia Market Size by Application
Table 5. Drug-Induced Dyskinesia Market Size Comparison by Region (M USD)
Table 6. Global Drug-Induced Dyskinesia Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Drug-Induced Dyskinesia Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Drug-Induced Dyskinesia Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Drug-Induced Dyskinesia Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Induced Dyskinesia as of 2025)
Table 11. Global Market Drug-Induced Dyskinesia Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Drug-Induced Dyskinesia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug-Induced Dyskinesia Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Drug-Induced Dyskinesia Sales by Type (K MT)
Table 27. Global Drug-Induced Dyskinesia Market Size by Type (M USD)
Table 28. Global Drug-Induced Dyskinesia Sales (K MT) by Type (2020-2025)
Table 29. Global Drug-Induced Dyskinesia Sales Market Share by Type (2020-2025)
Table 30. Global Drug-Induced Dyskinesia Market Size (M USD) by Type (2020-2025)
Table 31. Global Drug-Induced Dyskinesia Market Share by Type (2020-2025)
Table 32. Global Drug-Induced Dyskinesia Price (USD/KG) by Type (2020-2025)
Table 33. Global Drug-Induced Dyskinesia Sales (K MT) by Application
Table 34. Global Drug-Induced Dyskinesia Market Size by Application
Table 35. Global Drug-Induced Dyskinesia Sales by Application (2020-2025) & (K MT)
Table 36. Global Drug-Induced Dyskinesia Sales Market Share by Application (2020-2025)
Table 37. Global Drug-Induced Dyskinesia Market Size by Application (2020-2025) & (M USD)
Table 38. Global Drug-Induced Dyskinesia Market Share by Application (2020-2025)
Table 39. Global Drug-Induced Dyskinesia Sales Growth Rate by Application (2020-2025)
Table 40. Global Drug-Induced Dyskinesia Sales by Region (2020-2025) & (K MT)
Table 41. Global Drug-Induced Dyskinesia Sales Market Share by Region (2020-2025)
Table 42. Global Drug-Induced Dyskinesia Market Size by Region (2020-2025) & (M USD)
Table 43. Global Drug-Induced Dyskinesia Market Size by Region (2020-2025)
Table 44. North America Drug-Induced Dyskinesia Sales by Country (2020-2025) & (K MT)
Table 45. North America Drug-Induced Dyskinesia Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Drug-Induced Dyskinesia Sales by Country (2020-2025) & (K MT)
Table 47. Europe Drug-Induced Dyskinesia Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Drug-Induced Dyskinesia Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Drug-Induced Dyskinesia Market Size by Region (2020-2025) & (M USD)
Table 50. South America Drug-Induced Dyskinesia Sales by Country (2020-2025) & (K MT)
Table 51. South America Drug-Induced Dyskinesia Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Drug-Induced Dyskinesia Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Drug-Induced Dyskinesia Market Size by Region (2020-2025) & (M USD)
Table 54. Global Drug-Induced Dyskinesia Production (K MT) by Region(2020-2025)
Table 55. Global Drug-Induced Dyskinesia Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Drug-Induced Dyskinesia Revenue Market Share by Region (2020-2025)
Table 57. Global Drug-Induced Dyskinesia Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Drug-Induced Dyskinesia Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Drug-Induced Dyskinesia Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Drug-Induced Dyskinesia Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Drug-Induced Dyskinesia Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Neurocrine Bioscience Basic Information
Table 63. Neurocrine Bioscience Drug-Induced Dyskinesia Product Overview
Table 64. Neurocrine Bioscience Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Neurocrine Bioscience Business Overview
Table 66. Neurocrine Bioscience SWOT Analysis
Table 67. Neurocrine Bioscience Recent Developments
Table 68. Teva Pharmaceuticals Basic Information
Table 69. Teva Pharmaceuticals Drug-Induced Dyskinesia Product Overview
Table 70. Teva Pharmaceuticals Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Teva Pharmaceuticals Business Overview
Table 72. Teva Pharmaceuticals SWOT Analysis
Table 73. Teva Pharmaceuticals Recent Developments
Table 74. Sun Pharmaceutical Industries Basic Information
Table 75. Sun Pharmaceutical Industries Drug-Induced Dyskinesia Product Overview
Table 76. Sun Pharmaceutical Industries Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sun Pharmaceutical Industries Business Overview
Table 78. Sun Pharmaceutical Industries SWOT Analysis
Table 79. Sun Pharmaceutical Industries Recent Developments
Table 80. SteriMax Basic Information
Table 81. SteriMax Drug-Induced Dyskinesia Product Overview
Table 82. SteriMax Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. SteriMax Business Overview
Table 84. SteriMax Recent Developments
Table 85. Lannett Basic Information
Table 86. Lannett Drug-Induced Dyskinesia Product Overview
Table 87. Lannett Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Lannett Business Overview
Table 89. Lannett Recent Developments
Table 90. Adamas Pharmaceuticals Basic Information
Table 91. Adamas Pharmaceuticals Drug-Induced Dyskinesia Product Overview
Table 92. Adamas Pharmaceuticals Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Adamas Pharmaceuticals Business Overview
Table 94. Adamas Pharmaceuticals Recent Developments
Table 95. Sanis Basic Information
Table 96. Sanis Drug-Induced Dyskinesia Product Overview
Table 97. Sanis Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Sanis Business Overview
Table 99. Sanis Recent Developments
Table 100. AbbVie Basic Information
Table 101. AbbVie Drug-Induced Dyskinesia Product Overview
Table 102. AbbVie Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. AbbVie Business Overview
Table 104. AbbVie Recent Developments
Table 105. Global Drug-Induced Dyskinesia Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Drug-Induced Dyskinesia Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Drug-Induced Dyskinesia Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Drug-Induced Dyskinesia Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Drug-Induced Dyskinesia Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Drug-Induced Dyskinesia Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Drug-Induced Dyskinesia Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Drug-Induced Dyskinesia Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Drug-Induced Dyskinesia Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Drug-Induced Dyskinesia Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Drug-Induced Dyskinesia Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Drug-Induced Dyskinesia Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Drug-Induced Dyskinesia Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Drug-Induced Dyskinesia Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Drug-Induced Dyskinesia Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Drug-Induced Dyskinesia Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Drug-Induced Dyskinesia Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drug-Induced Dyskinesia Market Size by Type (M USD)
Table 4. Global Drug-Induced Dyskinesia Market Size by Application
Table 5. Drug-Induced Dyskinesia Market Size Comparison by Region (M USD)
Table 6. Global Drug-Induced Dyskinesia Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Drug-Induced Dyskinesia Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Drug-Induced Dyskinesia Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Drug-Induced Dyskinesia Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Induced Dyskinesia as of 2025)
Table 11. Global Market Drug-Induced Dyskinesia Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Drug-Induced Dyskinesia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug-Induced Dyskinesia Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Drug-Induced Dyskinesia Sales by Type (K MT)
Table 27. Global Drug-Induced Dyskinesia Market Size by Type (M USD)
Table 28. Global Drug-Induced Dyskinesia Sales (K MT) by Type (2020-2025)
Table 29. Global Drug-Induced Dyskinesia Sales Market Share by Type (2020-2025)
Table 30. Global Drug-Induced Dyskinesia Market Size (M USD) by Type (2020-2025)
Table 31. Global Drug-Induced Dyskinesia Market Share by Type (2020-2025)
Table 32. Global Drug-Induced Dyskinesia Price (USD/KG) by Type (2020-2025)
Table 33. Global Drug-Induced Dyskinesia Sales (K MT) by Application
Table 34. Global Drug-Induced Dyskinesia Market Size by Application
Table 35. Global Drug-Induced Dyskinesia Sales by Application (2020-2025) & (K MT)
Table 36. Global Drug-Induced Dyskinesia Sales Market Share by Application (2020-2025)
Table 37. Global Drug-Induced Dyskinesia Market Size by Application (2020-2025) & (M USD)
Table 38. Global Drug-Induced Dyskinesia Market Share by Application (2020-2025)
Table 39. Global Drug-Induced Dyskinesia Sales Growth Rate by Application (2020-2025)
Table 40. Global Drug-Induced Dyskinesia Sales by Region (2020-2025) & (K MT)
Table 41. Global Drug-Induced Dyskinesia Sales Market Share by Region (2020-2025)
Table 42. Global Drug-Induced Dyskinesia Market Size by Region (2020-2025) & (M USD)
Table 43. Global Drug-Induced Dyskinesia Market Size by Region (2020-2025)
Table 44. North America Drug-Induced Dyskinesia Sales by Country (2020-2025) & (K MT)
Table 45. North America Drug-Induced Dyskinesia Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Drug-Induced Dyskinesia Sales by Country (2020-2025) & (K MT)
Table 47. Europe Drug-Induced Dyskinesia Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Drug-Induced Dyskinesia Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Drug-Induced Dyskinesia Market Size by Region (2020-2025) & (M USD)
Table 50. South America Drug-Induced Dyskinesia Sales by Country (2020-2025) & (K MT)
Table 51. South America Drug-Induced Dyskinesia Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Drug-Induced Dyskinesia Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Drug-Induced Dyskinesia Market Size by Region (2020-2025) & (M USD)
Table 54. Global Drug-Induced Dyskinesia Production (K MT) by Region(2020-2025)
Table 55. Global Drug-Induced Dyskinesia Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Drug-Induced Dyskinesia Revenue Market Share by Region (2020-2025)
Table 57. Global Drug-Induced Dyskinesia Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Drug-Induced Dyskinesia Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Drug-Induced Dyskinesia Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Drug-Induced Dyskinesia Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Drug-Induced Dyskinesia Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Neurocrine Bioscience Basic Information
Table 63. Neurocrine Bioscience Drug-Induced Dyskinesia Product Overview
Table 64. Neurocrine Bioscience Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Neurocrine Bioscience Business Overview
Table 66. Neurocrine Bioscience SWOT Analysis
Table 67. Neurocrine Bioscience Recent Developments
Table 68. Teva Pharmaceuticals Basic Information
Table 69. Teva Pharmaceuticals Drug-Induced Dyskinesia Product Overview
Table 70. Teva Pharmaceuticals Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Teva Pharmaceuticals Business Overview
Table 72. Teva Pharmaceuticals SWOT Analysis
Table 73. Teva Pharmaceuticals Recent Developments
Table 74. Sun Pharmaceutical Industries Basic Information
Table 75. Sun Pharmaceutical Industries Drug-Induced Dyskinesia Product Overview
Table 76. Sun Pharmaceutical Industries Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sun Pharmaceutical Industries Business Overview
Table 78. Sun Pharmaceutical Industries SWOT Analysis
Table 79. Sun Pharmaceutical Industries Recent Developments
Table 80. SteriMax Basic Information
Table 81. SteriMax Drug-Induced Dyskinesia Product Overview
Table 82. SteriMax Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. SteriMax Business Overview
Table 84. SteriMax Recent Developments
Table 85. Lannett Basic Information
Table 86. Lannett Drug-Induced Dyskinesia Product Overview
Table 87. Lannett Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Lannett Business Overview
Table 89. Lannett Recent Developments
Table 90. Adamas Pharmaceuticals Basic Information
Table 91. Adamas Pharmaceuticals Drug-Induced Dyskinesia Product Overview
Table 92. Adamas Pharmaceuticals Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Adamas Pharmaceuticals Business Overview
Table 94. Adamas Pharmaceuticals Recent Developments
Table 95. Sanis Basic Information
Table 96. Sanis Drug-Induced Dyskinesia Product Overview
Table 97. Sanis Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Sanis Business Overview
Table 99. Sanis Recent Developments
Table 100. AbbVie Basic Information
Table 101. AbbVie Drug-Induced Dyskinesia Product Overview
Table 102. AbbVie Drug-Induced Dyskinesia Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. AbbVie Business Overview
Table 104. AbbVie Recent Developments
Table 105. Global Drug-Induced Dyskinesia Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Drug-Induced Dyskinesia Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Drug-Induced Dyskinesia Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Drug-Induced Dyskinesia Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Drug-Induced Dyskinesia Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Drug-Induced Dyskinesia Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Drug-Induced Dyskinesia Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Drug-Induced Dyskinesia Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Drug-Induced Dyskinesia Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Drug-Induced Dyskinesia Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Drug-Induced Dyskinesia Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Drug-Induced Dyskinesia Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Drug-Induced Dyskinesia Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Drug-Induced Dyskinesia Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Drug-Induced Dyskinesia Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Drug-Induced Dyskinesia Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Drug-Induced Dyskinesia Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Drug-Induced Dyskinesia
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug-Induced Dyskinesia Market Size (M USD), 2025-2035
Figure 5. Global Drug-Induced Dyskinesia Market Size (M USD) (2020-2035)
Figure 6. Global Drug-Induced Dyskinesia Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug-Induced Dyskinesia Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Drug-Induced Dyskinesia Product Life Cycle
Figure 13. Drug-Induced Dyskinesia Sales Share by Manufacturers in 2025
Figure 14. Global Drug-Induced Dyskinesia Revenue Share by Manufacturers in 2025
Figure 15. Drug-Induced Dyskinesia Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Drug-Induced Dyskinesia Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drug-Induced Dyskinesia Revenue in 2025
Figure 18. Industry Chain Map of Drug-Induced Dyskinesia
Figure 19. Global Drug-Induced Dyskinesia Market PEST Analysis
Figure 20. Global Drug-Induced Dyskinesia Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Drug-Induced Dyskinesia Market Share by Type
Figure 27. Sales Market Share of Drug-Induced Dyskinesia by Type (2020-2025)
Figure 28. Sales Market Share of Drug-Induced Dyskinesia by Type in 2025
Figure 29. Market Share of Drug-Induced Dyskinesia by Type (2020-2025)
Figure 30. Market Share of Drug-Induced Dyskinesia by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Drug-Induced Dyskinesia Market Share by Application
Figure 33. Global Drug-Induced Dyskinesia Sales Market Share by Application (2020-2025)
Figure 34. Global Drug-Induced Dyskinesia Sales Market Share by Application in 2025
Figure 35. Global Drug-Induced Dyskinesia Market Share by Application (2020-2025)
Figure 36. Global Drug-Induced Dyskinesia Market Share by Application in 2025
Figure 37. Global Drug-Induced Dyskinesia Sales Growth Rate by Application (2020-2025)
Figure 38. Global Drug-Induced Dyskinesia Sales Market Share by Region (2020-2025)
Figure 39. Global Drug-Induced Dyskinesia Market Size by Region (2020-2025)
Figure 40. North America Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Drug-Induced Dyskinesia Sales Market Share by Country in 2024
Figure 43. North America Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Drug-Induced Dyskinesia Market Size by Country in 2024
Figure 45. U.S. Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Drug-Induced Dyskinesia Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Drug-Induced Dyskinesia Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Drug-Induced Dyskinesia Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Drug-Induced Dyskinesia Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Drug-Induced Dyskinesia Sales Market Share by Country in 2024
Figure 53. Europe Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Drug-Induced Dyskinesia Market Size by Country in 2024
Figure 55. Germany Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Drug-Induced Dyskinesia Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Drug-Induced Dyskinesia Sales Market Share by Region in 2024
Figure 67. Asia Pacific Drug-Induced Dyskinesia Market Size by Region in 2024
Figure 68. China Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Drug-Induced Dyskinesia Sales and Growth Rate (K MT)
Figure 79. South America Drug-Induced Dyskinesia Sales Market Share by Country in 2024
Figure 80. South America Drug-Induced Dyskinesia Market Size and Growth Rate (M USD)
Figure 81. South America Drug-Induced Dyskinesia Market Size by Country in 2024
Figure 82. Brazil Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Drug-Induced Dyskinesia Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Drug-Induced Dyskinesia Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Drug-Induced Dyskinesia Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Drug-Induced Dyskinesia Market Size by Region in 2024
Figure 92. Saudi Arabia Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Drug-Induced Dyskinesia Production Market Share by Region (2020-2025)
Figure 103. North America Drug-Induced Dyskinesia Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Drug-Induced Dyskinesia Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Drug-Induced Dyskinesia Production (K MT) Growth Rate (2020-2025)
Figure 106. China Drug-Induced Dyskinesia Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Drug-Induced Dyskinesia Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Drug-Induced Dyskinesia Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Drug-Induced Dyskinesia Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Drug-Induced Dyskinesia Market Share Forecast by Type (2026-2035)
Figure 111. Global Drug-Induced Dyskinesia Sales Forecast by Application (2026-2035)
Figure 112. Global Drug-Induced Dyskinesia Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Drug-Induced Dyskinesia
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug-Induced Dyskinesia Market Size (M USD), 2025-2035
Figure 5. Global Drug-Induced Dyskinesia Market Size (M USD) (2020-2035)
Figure 6. Global Drug-Induced Dyskinesia Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug-Induced Dyskinesia Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Drug-Induced Dyskinesia Product Life Cycle
Figure 13. Drug-Induced Dyskinesia Sales Share by Manufacturers in 2025
Figure 14. Global Drug-Induced Dyskinesia Revenue Share by Manufacturers in 2025
Figure 15. Drug-Induced Dyskinesia Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Drug-Induced Dyskinesia Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drug-Induced Dyskinesia Revenue in 2025
Figure 18. Industry Chain Map of Drug-Induced Dyskinesia
Figure 19. Global Drug-Induced Dyskinesia Market PEST Analysis
Figure 20. Global Drug-Induced Dyskinesia Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Drug-Induced Dyskinesia Market Share by Type
Figure 27. Sales Market Share of Drug-Induced Dyskinesia by Type (2020-2025)
Figure 28. Sales Market Share of Drug-Induced Dyskinesia by Type in 2025
Figure 29. Market Share of Drug-Induced Dyskinesia by Type (2020-2025)
Figure 30. Market Share of Drug-Induced Dyskinesia by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Drug-Induced Dyskinesia Market Share by Application
Figure 33. Global Drug-Induced Dyskinesia Sales Market Share by Application (2020-2025)
Figure 34. Global Drug-Induced Dyskinesia Sales Market Share by Application in 2025
Figure 35. Global Drug-Induced Dyskinesia Market Share by Application (2020-2025)
Figure 36. Global Drug-Induced Dyskinesia Market Share by Application in 2025
Figure 37. Global Drug-Induced Dyskinesia Sales Growth Rate by Application (2020-2025)
Figure 38. Global Drug-Induced Dyskinesia Sales Market Share by Region (2020-2025)
Figure 39. Global Drug-Induced Dyskinesia Market Size by Region (2020-2025)
Figure 40. North America Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Drug-Induced Dyskinesia Sales Market Share by Country in 2024
Figure 43. North America Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Drug-Induced Dyskinesia Market Size by Country in 2024
Figure 45. U.S. Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Drug-Induced Dyskinesia Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Drug-Induced Dyskinesia Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Drug-Induced Dyskinesia Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Drug-Induced Dyskinesia Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Drug-Induced Dyskinesia Sales Market Share by Country in 2024
Figure 53. Europe Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Drug-Induced Dyskinesia Market Size by Country in 2024
Figure 55. Germany Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Drug-Induced Dyskinesia Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Drug-Induced Dyskinesia Sales Market Share by Region in 2024
Figure 67. Asia Pacific Drug-Induced Dyskinesia Market Size by Region in 2024
Figure 68. China Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Drug-Induced Dyskinesia Sales and Growth Rate (K MT)
Figure 79. South America Drug-Induced Dyskinesia Sales Market Share by Country in 2024
Figure 80. South America Drug-Induced Dyskinesia Market Size and Growth Rate (M USD)
Figure 81. South America Drug-Induced Dyskinesia Market Size by Country in 2024
Figure 82. Brazil Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Drug-Induced Dyskinesia Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Drug-Induced Dyskinesia Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Drug-Induced Dyskinesia Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Drug-Induced Dyskinesia Market Size by Region in 2024
Figure 92. Saudi Arabia Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Drug-Induced Dyskinesia Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Drug-Induced Dyskinesia Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Drug-Induced Dyskinesia Production Market Share by Region (2020-2025)
Figure 103. North America Drug-Induced Dyskinesia Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Drug-Induced Dyskinesia Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Drug-Induced Dyskinesia Production (K MT) Growth Rate (2020-2025)
Figure 106. China Drug-Induced Dyskinesia Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Drug-Induced Dyskinesia Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Drug-Induced Dyskinesia Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Drug-Induced Dyskinesia Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Drug-Induced Dyskinesia Market Share Forecast by Type (2026-2035)
Figure 111. Global Drug-Induced Dyskinesia Sales Forecast by Application (2026-2035)
Figure 112. Global Drug-Induced Dyskinesia Market Share Forecast by Application (2026-2035)
